This clinical trial conducted by conducted by Paula Groncy, MD and her team at the MemorialCare Health System is called Pathfinder3. Participation on this study is for patients have hemophilia A and are scheduled to undergo a surgery, which will require several days of treatment with N8-GP. These patients are also already receiving the trial drug N8-GP from the Pathfinder2 trial. The purpose of this research trial is to evaluate the effectiveness of N8-GP in preventing bleeding during surgery and in stopping bleeding during and after surgery and also to allow you to continue treatment with N8-GP during your surgery procedure.
NN7088-3860 – Efficacy and Safety of NNC 0129-0000-1003 During Surgical Procedures in Patients with Haemophilia A
138-12Principal Investigator: Conducted at:
Miller Children's & Women's Hospital Long BeachCurrently enrolling additional patients:
7-17 years; 18 years & upGender:
Male & Female